Three-year-old Gurmoh’s ability to walk and talk is at risk due to a rare, progressive neurodegenerative disease
Article content
A Surrey family is racing against time to raise enough money for a gene-editing procedure that could save their three-year-old son’s ability to walk.
Article content
When Gurmoh was struggling to walk on his own at 1.5 years of age, his parents Stalin and Navpreet Gill knew something was wrong.
Article content
Article content
The parents were initially told the issue would resolve itself, but Gurmoh’s capabilities have only got worse.
Article content
Story continues below
Article content
Earlier this year, Gurmoh was diagnosed with a rare, progressive neurodegenerative disease called Hereditary Spastic Paraplegia Type 4, which causes weakness and stiffness in the legs.
Article content
Sunrise
Article content
“This is the only thing we have on our mind, it’s all we do, all we care about,” Stalin said.
Article content
Gurmoh underwent an MRI and blood testing, which showed no abnormalities, the father said.
Article content
He was first diagnosed with cerebral palsy after his legs completely gave out and he was rushed to B.C. Children’s Hospital. The family didn’t get the right answer until April.
Article content
Since then, the family has been searching for treatment, as there is no known cure for the condition.
Article content
“My wife sent about 2,000 emails around the globe to all the researchers that were doing any sort of research on this disease,” Stalin said.
Article content
A doctor from McGill University, Dr. Ziv Gan-Or, responded and said he could develop a personalized gene therapy for Gurmoh.
Article content
“HSP is a rare disease found in about five out of 100,000 people. That means in Canada, there’s about 2,000 patients with this disease,” Gan-Or said in a statement.
Article content
The form of HSP Gurmoh has, Type 4, is the most common form of the disease, the doctor added.
Article content
Story continues below
Article content
“He is expected, as this disease progresses, to lose his ability to walk, his ability to talk, his ability to connect with people and he would be completely dependent on his environment and his caretakers,” Gan-Or said.
Article content
Read More
Article content
The doctor told the Gill family that the treatment would cost up to $8 million. The Gills reached out to the B.C. and federal governments, thinking they could receive some coverage.
Article content
“We were really happy, like someone is ready to make the therapy medicine within Canada,” Stalin said.
Article content
Article content
The provincial government informed the family it could not cover the treatment, so the family started fundraising. In total, $2.4 million has been raised, nearly reaching the initial $2.7 million goal to just kickstart the development of the gene therapy for Gurmoh.
Article content
Along with supporters, the Gills walked 120 kilometres from Vancouver to the B.C. legislature in Victoria from May 21 to 25. Last month, the family went to Ottawa and stood outside Parliament for three days until Minister of Health Marjorie Michel met with them and said she would reach out to Health Canada.
